small molecule

CETYLEV

ACETYLCYSTEINE

Loss of exclusivityMay 2032latest FDA-listed patent expiry
CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand nameCETYLEV
Active ingredientACETYLCYSTEINE
Strength500MG
Dosage formTABLET, EFFERVESCENT
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusDISCN

Listed patents

PatentExpiresType
8747894May 2032product
9561204May 2032use U-1373
9427421May 2032product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CETYLEV patent cliff — loss of exclusivity May 2032 | CliffBio